Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.

D'Asta M, Monaco C, Gulino FA, Ettore C, Incognito GG, Ettore G

Open source

DOI
10.1155/ogi/3792144
Published
2026
Container
Obstetrics and gynecology international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/ogi/3792144,
  title = {Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.},
  author = {D'Asta M and Monaco C and Gulino FA and Ettore C and Incognito GG and Ettore G},
  year = {2026},
  journal = {Obstetrics and gynecology international},
  doi = {10.1155/ogi/3792144},
  url = {https://doi.org/10.1155/ogi/3792144}
}

RIS

TY  - JOUR
TI  - Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.
AU  - D'Asta M
AU  - Monaco C
AU  - Gulino FA
AU  - Ettore C
AU  - Incognito GG
AU  - Ettore G
PY  - 2026
JO  - Obstetrics and gynecology international
DO  - 10.1155/ogi/3792144
UR  - https://doi.org/10.1155/ogi/3792144
ER  - 

APA

M, D., C, M., FA, G., C, E., GG, I., & G, E. (2026). Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.. Obstetrics and gynecology international. https://doi.org/10.1155/ogi/3792144

Source records